Finance

Lists
6534:TPE
CH Biotech R&D Co Ltd
NT$85,20
-0,93%
(-0,80) 1D
11 Nov., 13:30:13 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6534...
Open
NT$85,10
High
NT$86,20
Low
NT$85,10
Mkt. cap
8,76 mjd
Avg. vol.
66,91 k
Volume
24,16 k
Dividend
6,23%
Quarterly dividend
NT$1,33
Ex-dividend date
01 Sep. 2026
P/E ratio
14,53
52-wk high
NT$104,00
52-wk low
NT$77,60
EPS
NT$5,87
No. of employees
22
Open
NT$85,10
High
NT$86,20
Low
NT$85,10
Mkt. cap
8,76 mjd
Avg. vol.
66,91 k
Volume
24,16 k
Dividend
6,23%
Quarterly dividend
NT$1,33
Ex-dividend date
01 Sep. 2026
P/E ratio
14,53
52-wk high
NT$104,00
52-wk low
NT$77,60
EPS
NT$5,87
No. of employees
22
News stories
From web sources and news partners
About CH Biotech R&D Co Ltd
CEO-
Employees22
Founded2013
Headquarters-
SectorMaterials
Industry-
Websitechbio.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
216,68 m
328,38 m
869,50 m
459,43 m
Cost of goods sold
44,23 m
63,38 m
120,11 m
69,52 m
Cost of revenue
44,23 m
63,38 m
120,11 m
69,52 m
Research and development expenses
121,72 m
98,86 m
99,04 m
101,73 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99,03 m
124,14 m
132,18 m
117,46 m
Operating expense
221,16 m
223,35 m
231,23 m
219,18 m
Total operating expenses
265,39 m
286,73 m
351,33 m
288,70 m
Operating income
-48,71 m
41,65 m
518,17 m
170,72 m
Other non operating income
1,70 m
1,73 m
1,08 m
1,72 m
EBT including unusual items
-21,67 m
59,12 m
532,25 m
166,60 m
EBT excluding unusual items
-21,19 m
59,24 m
532,25 m
166,60 m
Income tax expense
-4,69 m
15,34 m
105,55 m
15,47 m
Effective tax rate
21,64%
25,94%
19,83%
9,28%
Other operating expenses
-
-
-
-
Net income
-16,94 m
43,80 m
426,70 m
151,13 m
Net profit margin
-7,82%
13,34%
49,07%
32,89%
Earnings per share
-
-
-
-
Interest and investment income
3,86 m
2,72 m
2,58 m
3,00 m
Interest expense
-4,90 m
-3,58 m
-3,28 m
-4,39 m
Net interest expenses
-1,04 m
-853,00 k
-703,00 k
-1,39 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,48 m
88,81 m
566,17 m
218,60 m
Gain or loss from assets sale
478,00 k
122,00 k
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme